Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-up: Studer UE, EORTC Genitourinary Cancer Group (Inselspital, Bern, Switzerland; et al) Eur Urol 2013 [Epub ahead of print]§

Publication date: 2014Source: Yearbook of Urology, Volume 2014Author(s): A.S. Kibel
Source: Yearbook of Urology - Category: Urology & Nephrology Source Type: research